GeneGenius
AI-Powered Genomic Interpretation Platform
About
Genomic sequencing has scaled rapidly, but interpretation remains the bottleneck. Turning raw genetic data into clinically actionable insights still takes days to weeks. GeneGenius is building AI-native infrastructure for genomic interpretation, transforming raw sequencing outputs into clinician-ready, evidence-traceable reports in minutes. Our platform combines automated evidence extraction, structured reasoning, and GPU-accelerated inference to deliver fast, reliable, and scalable clinical insights. Part of the NVIDIA Inception Program, leveraging GPU-accelerated infrastructure to support high-throughput genomic analysis. 🌐 https://genegenius.ai 📩 support@genegenius.ai
Product
- Value proposition
- Turns complex DNA data into clear, evidence-backed insights and research reports in minutes
- Target customers
- laboratories, genomic research teams, hospitals, academic medical centers, biobank programs, pharmaceutical partners
Founders
- Zuhra Maksudi — CEO & Co-Founder
- Mohd Sarfaraz F. — COO & Co-Founder
- Sagar V Gour — CTO
Products
Key features
Technologies
Integrations
Partnerships
News
- #genegenius #genomics #precisionmedicine #h100 #ai - LinkedIn · 2026-05-27T00:00:00.000Z
- GeneGenius Scales to 100+ Researchers in 35 Days - LinkedIn · 2026-04-06T00:00:00.000Z
- GeneGenius Meets AWS for Healthcare Innovation - LinkedIn · 2026-06-03T00:00:00.000Z
- NVIDIA Inception Program Boosts Medikal Africa's AI Mission · 2026-02-02T00:00:00.000Z
- Gene Genius: Prenetics dynamo Danny Yeung envisions a world ... · 2025-09-30T00:00:00.000Z
More links
Browse similar startups
Related startups
- GNOMX Corp. — New York, NY
- HekaHeart — New York, NY
- i-On By Dr. Xi — New York, NY
- Ilant Health — albany, NY
- Juniper — New York, NY
- Kennar Health — Hicksville, NY
- GeneMatrix AI — Chicago, IL
- GENITECH LLC — Dallas, TX
- Genix Therapeutics — Chicago, IL
- Gennao Bio — Hopewell, NJ
- Genomes2People — Boston, MA
- Genoxus — San Diego, CA
Profile updated Jul 29, 2026. Sources: genegenius.ai, linkedin.com, rarediseases.info.nih.gov


